+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Docetaxel"

From
From
From
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
From
From
Liver Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 239 Pages
  • China
From
Liver Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Companies in China

  • Report
  • September 2024
  • 69 Pages
  • China
From
From
Prostate Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Prostate Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 244 Pages
  • China
From
Loading Indicator

Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs. Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment. Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more